CME Group (NASDAQ:CME) Posts Earnings Results, Beats Estimates By $0.03 EPS

CME Group (NASDAQ:CME) released its earnings results on Wednesday. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03, Briefing.com reports. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. The firm’s revenue was up 18.4% on a year-over-year basis.

CME Group Trading Down 0.1 %

CME traded down $0.22 on Thursday, reaching $226.92. 49,406 shares of the company traded hands, compared to its average volume of 1,929,167. CME Group has a one year low of $190.70 and a one year high of $230.12. The firm has a fifty day simple moving average of $218.08 and a two-hundred day simple moving average of $208.66. The company has a market cap of $81.71 billion, a P/E ratio of 25.87, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.03%. CME Group’s payout ratio is 52.33%.

Insider Activity at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Bank of America raised their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Piper Sandler lifted their price target on CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a report on Tuesday, October 8th. Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday. Keefe, Bruyette & Woods lifted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Finally, The Goldman Sachs Group raised their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $220.87.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.